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HypogammaglobulinemiaAbstract Recurrent respiratory infections are important causes for bronchiectasis which can also
be caused by a severe or poorly treated single infective event. With the widespread usage of vaccines
for whooping cough and measles and the efﬁcacy of anti-tuberculosis chemotherapy, the latter
cause has receded as predisposing factor to developing bronchiectasis especially in the developed
world. Primary antibody deﬁciency syndromes (PADS) are uncommon causes for recurrent
respiratory infections and bronchiectasis. The importance of a timely diagnosis of such conditions
is that treatments are available and can prevent the development of bronchiectasis. I here report the
case of a young gentleman who suffered from recurrent pneumonias for seven years before identi-
fying common variable immunodeﬁciency disorder as the underlying disease.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Case report
A 26 year-old male presented with a 3 day history of fever,
productive cough of purulent sputum and right-sided
stitching chest pain. By examination, the patient looked pale,
dehydrated and underweight. Macular rash, which the patient
did not notice before, was noted in both lower limbs. Blood
pressure was 110/60 mmHg, respiratory rate was 24 bpm and
heart rate was 118 bpm and temperature was 39.5 C. Chest
examination revealed signs of consolidation overlying the
middle lobe. The patient gave a long history of recurrent
sinus infections and diarrhea as well as repeated hospitaladmissions for respiratory infections. Laboratory investiga-
tions were within normal limits except for mild leucocytosis
with neutrophilia and a high CRP level. Sputum culture
was sterile. The oldest radiology the patient possessed was
a chest CT dating from 2007 (Fig. 1A) showing middle lobe
consolidation and mild bronchiectatic changes in the left
lower lobe. A new chest X-ray (Fig. 1B) showed a middle
lobe consolidation. Given the previous history of a similar
consolidation, a ﬁberoptic bronchoscopy was performed to
evaluate the structure of the right bronchial tree. No abnor-
malities could be detected. The patient improved on empirical
antibiotics with normalization of the CRP and white cell
count. Drug reaction was suggested as the cause for skin
lesions. Six months later, the patient presented with similar
symptoms. Chest X-ray revealed right lower lobe consolida-
tion with effusion (Fig. 1C). Sputum and pleural ﬂuid
cultures were sterile. Bronchoscopy was repeated to perform
a bronchoalveolar lavage (BAL) for cellular and microbiolog-d.
Figure 1 (A) Chest Ct shows middle lobe consolidation, and minimal bronchiectasis at left lower lobe. (B) Chest X-ray: middle lobe
consolidation. (C) Right lower lobe consolidation with effusion. (D) Left lower lobe consolidation, with middle lobe bronchiectasis.
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were all negative. Cellular analysis revealed predominance
of neutrophils. After improvement, patient was discharged
with the advice to receive inﬂuenza and pneumococcal vac-
cine. The patient came back 3 months later with pneumonia
in the left lower lobe. In addition to the left lower lobar
consolidation, the chest CT (Fig. 1D) showed cylindrical
bronchiectasis in the right middle and lower lobes. Immune
deﬁciency was suspected, and given the normal white cell
count, a humoral component was sought. Serum protein elec-
trophoresis (Fig. 2) conﬁrmed the presence of hypogamma-
globulinemia. Serology for HIV, HCV, HBV infections,
rheumatoid arthritis and systemic lupus were all done to
exclude a secondary cause for hypogammaglobulinemia.
Results were all negative. An abdominal ultrasound revealed
splenomegaly. Very low levels of IgM (<0.05 g/L) and IgG
(<0.3 g/L) were recorded. Given these ﬁndings of repeated
infections, low levels of antibodies and poor response to vac-
cination, the diagnosis of common variable immunodeﬁciency
disorder (CVID) was made. The skin lesions were diagnosed
as cutaneous granulomas which, together with splenomegaly,
are recognized complications of CVID. Intravenous immuno-
globulins (IVIGs) were prescribed to prevent recurrence ofinfection. It is hoped that following a proper treatment regi-
men will halt the progression of the structural lung damage.
Discussion
Antibodies (immunoglobulins) are synthesized by plasma cells,
which are themselves the result of the development and differ-
entiation of B lymphocytes. Any cause that inhibits the devel-
opment of the B cell lineage or its function as a mature cell
may result in decreased levels of serum immunoglobulins
(hypogammaglobulinemia) [1].
Primary antibody deﬁciency syndromes (PADS) comprise
a wide variety of disorders characterized by defective anti-
body production in response to microbes, resulting in recur-
rent infections in the sinopulmonary tract and the gastro-
intestinal tract. Recurrent pulmonary infections lead eventu-
ally to bronchiectasis. In addition, patients with common
variable deﬁciency (CVID), one of the frequent forms of
PADS, may develop inﬂammatory lung disease, often associ-
ated with multi-system granulomatous disease [2]. PADS fall
into either of two groups: a group of disorders with well-
identiﬁed genetic alterations (e.g. X-linked agammaglobulin-
emia and autosomal recessive agammaglobulinemia) and
Figure 2 Serum protein electrophoresis shows hypogammaglobulinemia.
Migratory pneumonia caused by common variable immunodeﬁciency disorder 147another group with unknown genetic background. The latter
group constitutes the largest one and includes CVID, IgG
subclass deﬁciencies, IgA deﬁciency, and selective antibody
deﬁciency [3].
Before diagnosing a primary antibody deﬁciency disorder,
secondary causes for antibody deﬁciency need to be excluded.
These conditions include: prolonged courses of glucocorticoids
and immunomodulatory drugs, surgery and trauma, extreme
environmental conditions, profound metabolic abnormalities,
autoimmune diseases and chronic infections, such as those
caused by HIV [4].
CVID is the archetype of PADS and is characterized by
impaired B cell differentiation with defective immunoglobulin
production. It is the most prevalent form of severe antibody
deﬁciency affecting both children and adults with an estimated
prevalence of 1 in 25,000 individuals [5], hence the term ‘‘com-
mon.’’ Variability of the presentation, as the name implies, is
manifested by heterogenous presentations, including recurrent
infections, chronic lung disease, autoimmune disorders, gastro-
intestinal disease, and an increased susceptibility to lymphoma
[2]. The age of onset is typically after puberty and before
30 years of age, with some evidence of a bimodal distribution
demonstrating peaks between 1 and 5 years, and 18 and
25 years [6]. CVID is deﬁned by the triad of: (a) markedly
reduced serum concentrations of IgG, in combination with
low levels of IgA and/or IgM, (b) poor or absent response to
immunization and (c) absence of any other deﬁned immunode-
ﬁciency state [6]. Sinopulmonary infections, including pneumo-
nia, bronchitis, and sinusitis, as well as otitis and
conjunctivitis, are observed in the majority of patients with
CVID. These infections may be acute, chronic, or recurrent.
Patients are particularly susceptible to infection with Pneumo-coccus, Hemophilus, and Mycoplasma species [7]. Diarrhea
also occurs very commonly, with malabsorption and weight
loss also reported [5]. Bronchiectasis, deﬁned as irreversible
dilatation of large and medium-sized bronchi, is one of the
most feared complications of the repeated pyogenic respiratory
infections affecting CVID patients. The presence of bronchiec-
tasis at diagnosis predicts poor outcome, while early diagnosis
and aggressive management predicts good outcome [8].
The presentation of CVID might mimic other famous
causes of bronchiectasis like primary ciliary dyskinesia
(PCD) and cystic ﬁbrosis (CF). PCD is associated frequently
with infertility and nose/sinus problems since infancy. CF
can be diagnosed with a positive chloride sweat test as well
as genetic testing. Antibody deﬁciency is not demonstrable in
both of these conditions.
The treatment of CVID is centered on preventing the recur-
rent respiratory infections from inﬂicting irreversible structural
lung damage. This is achieved via the two cornerstones of
management; intravenous replacement of immunoglobulins
(IVIG) and timely eradication of respiratory infections. Early
identiﬁcation and aggressive management of pyogenic infec-
tions with prolonged courses on antibiotics will guard against
development of bronchiectasis. Immunoglobulin is adminis-
tered intravenously every 2–4 weeks or subcutaneously every
1–2 weeks, with a usual starting dose of 0Æ4–0Æ6 g/kg/month
[9]. To date, routine antibiotic prophylaxis is not recom-
mended. Some authors however advocate prophylactic antibi-
otics in patients with recurrent infections despite adequate IG
replacement. The proposed regimen is based on macrolide
antibiotics due to their anti-inﬂammatory as well as anti-
microbial properties, with prescription frequency similar to
that of CF (500 mg tab, 3 times a week) [2].
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